Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection

Background Hepatitis C virus (HCV) infection is a worldwide health problem. Liver fibrosis has been a major topic of research for decades. However, recent data have shown the occurrence of fibrosis fall in a wide spectrum of chronic liver diseases. Aim We aimed to evaluate the changes in transient e...

Full description

Bibliographic Details
Main Authors: Mohamed M Sakr, Ahmed I El-Agrody, Hesham A Farrag
Format: Article
Language:English
Published: SpringerOpen 2019-01-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
Online Access:http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=4;spage=473;epage=479;aulast=Sakr
_version_ 1818533710284193792
author Mohamed M Sakr
Ahmed I El-Agrody
Hesham A Farrag
author_facet Mohamed M Sakr
Ahmed I El-Agrody
Hesham A Farrag
author_sort Mohamed M Sakr
collection DOAJ
description Background Hepatitis C virus (HCV) infection is a worldwide health problem. Liver fibrosis has been a major topic of research for decades. However, recent data have shown the occurrence of fibrosis fall in a wide spectrum of chronic liver diseases. Aim We aimed to evaluate the changes in transient elastography (TE) values of different direct-acting antivirals regimens in HCV chronic liver disease patients. Settings and design This observational analytic study was carried out at the Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt. Participants and methods 100 Egyptian chronic hepatitis C patients were recruited into this study. All participants were included according to the inclusion criteria approved by the national committee in Egypt for control of viral hepatitis. They were subjected to a thorough assessment of history and clinical examination, routine investigations, ECG, radiological examination, and TE 2 weeks before treatment initiation, at the end of the course, and 6 months after treatment. Results There was a significant improvement in liver stiffness (LS) values in cirrhotic patients, but they still had cirrhosis, with lower LS values than pretreatment values. This study reported a significant decrease 12 weeks after the end of treatment for LS measurements and validated fibrosis scores such as FIB-4 and APRI. Patients with F4 grade fibrosis showed a significant improvement in the score, and the percentage decreased from 56% before treatment to 42 and 38% after sustained virological response 1 and sustained virological response 2, respectively. Conclusion Direct-acting antivirals based treatment results in a significant improvement in hepatic fibrosis measures, indicated by TE as well as noninvasive fibrosis scores such as fibrosis score (FIB-4) and APRI.
first_indexed 2024-12-11T18:02:20Z
format Article
id doaj.art-c9933b221fe9414987975559b1d6e618
institution Directory Open Access Journal
issn 1110-7782
2090-9098
language English
last_indexed 2024-12-11T18:02:20Z
publishDate 2019-01-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Internal Medicine
spelling doaj.art-c9933b221fe9414987975559b1d6e6182022-12-22T00:55:50ZengSpringerOpenThe Egyptian Journal of Internal Medicine1110-77822090-90982019-01-0131447347910.4103/ejim.ejim_43_19Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infectionMohamed M SakrAhmed I El-AgrodyHesham A FarragBackground Hepatitis C virus (HCV) infection is a worldwide health problem. Liver fibrosis has been a major topic of research for decades. However, recent data have shown the occurrence of fibrosis fall in a wide spectrum of chronic liver diseases. Aim We aimed to evaluate the changes in transient elastography (TE) values of different direct-acting antivirals regimens in HCV chronic liver disease patients. Settings and design This observational analytic study was carried out at the Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt. Participants and methods 100 Egyptian chronic hepatitis C patients were recruited into this study. All participants were included according to the inclusion criteria approved by the national committee in Egypt for control of viral hepatitis. They were subjected to a thorough assessment of history and clinical examination, routine investigations, ECG, radiological examination, and TE 2 weeks before treatment initiation, at the end of the course, and 6 months after treatment. Results There was a significant improvement in liver stiffness (LS) values in cirrhotic patients, but they still had cirrhosis, with lower LS values than pretreatment values. This study reported a significant decrease 12 weeks after the end of treatment for LS measurements and validated fibrosis scores such as FIB-4 and APRI. Patients with F4 grade fibrosis showed a significant improvement in the score, and the percentage decreased from 56% before treatment to 42 and 38% after sustained virological response 1 and sustained virological response 2, respectively. Conclusion Direct-acting antivirals based treatment results in a significant improvement in hepatic fibrosis measures, indicated by TE as well as noninvasive fibrosis scores such as fibrosis score (FIB-4) and APRI.http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=4;spage=473;epage=479;aulast=Sakrdirect-acting antiviralshepatitis c virustransient elastography
spellingShingle Mohamed M Sakr
Ahmed I El-Agrody
Hesham A Farrag
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
The Egyptian Journal of Internal Medicine
direct-acting antivirals
hepatitis c virus
transient elastography
title Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
title_full Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
title_fullStr Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
title_full_unstemmed Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
title_short Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
title_sort effect of direct acting antivirals on elastographic measures in patients with chronic hepatitis c virus infection
topic direct-acting antivirals
hepatitis c virus
transient elastography
url http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=4;spage=473;epage=479;aulast=Sakr
work_keys_str_mv AT mohamedmsakr effectofdirectactingantiviralsonelastographicmeasuresinpatientswithchronichepatitiscvirusinfection
AT ahmedielagrody effectofdirectactingantiviralsonelastographicmeasuresinpatientswithchronichepatitiscvirusinfection
AT heshamafarrag effectofdirectactingantiviralsonelastographicmeasuresinpatientswithchronichepatitiscvirusinfection